Literature DB >> 15866176

A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II.

Richard J Sessler1, Noa Noy.   

Abstract

Primary sequences of proteins often contain motifs that serve as "signatures" for subcellular targeting, such as a nuclear localization signal (NLS). However, many nuclear proteins do not harbor a recognizable NLS, and the pathways that mediate their nuclear translocation are unknown. This work focuses on CRABP-II, a cytosolic protein that moves to the nucleus upon binding of retinoic acid. While CRABP-II does not contain an NLS in its primary sequence, such a motif could be recognized in the protein's tertiary structure. We map the retinoic acid-induced structural rearrangements that result in the presence of this NLS in holo- but not apo-CRABP-II. The signal, whose three-dimensional configuration aligns strikingly well with a "classical" NLS, mediates ligand-induced association of CRABP-II with importin alpha and is critical for nuclear localization of the protein. The ligand-controlled NLS "switch" of CRABP-II may represent a general mechanism for posttranslational regulation of the subcellular distribution of a protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866176     DOI: 10.1016/j.molcel.2005.03.026

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  83 in total

1.  Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.

Authors:  Benito Campos; Franz-Simon Centner; Justo Lorenzo Bermejo; Ramadan Ali; Katharina Dorsch; Feng Wan; Jörg Felsberg; Rezvan Ahmadi; Niels Grabe; Guido Reifenberger; Andreas Unterberg; Jürgen Burhenne; Christel Herold-Mende
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Sterol-dependent nuclear import of ORP1S promotes LXR regulated trans-activation of apoE.

Authors:  Sungsoo Lee; Ping-Yuan Wang; Yangsik Jeong; David J Mangelsdorf; Richard G W Anderson; Peter Michaely
Journal:  Exp Cell Res       Date:  2012-06-20       Impact factor: 3.905

3.  Transcript stabilization by the RNA-binding protein HuR is regulated by cellular retinoic acid-binding protein 2.

Authors:  Amanda C Vreeland; Shuiliang Yu; Liraz Levi; Daniella de Barros Rossetto; Noa Noy
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

4.  SIRT1-mediated deacetylation of CRABPII regulates cellular retinoic acid signaling and modulates embryonic stem cell differentiation.

Authors:  Shuang Tang; Gang Huang; Wei Fan; Yue Chen; James M Ward; Xiaojiang Xu; Qing Xu; Ashley Kang; Michael W McBurney; David C Fargo; Guang Hu; Eveline Baumgart-Vogt; Yingming Zhao; Xiaoling Li
Journal:  Mol Cell       Date:  2014-08-21       Impact factor: 17.970

5.  Zinc regulation of transcriptional activity during retinoic acid-induced neuronal differentiation.

Authors:  Deborah R Morris; Cathy W Levenson
Journal:  J Nutr Biochem       Date:  2013-09-09       Impact factor: 6.048

6.  Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies.

Authors:  Junning Yang; Chuanshen Wu; Ioana Stefanescu; Arie Horowitz
Journal:  J Vis Exp       Date:  2017-04-22       Impact factor: 1.355

7.  Structural basis for activation of fatty acid-binding protein 4.

Authors:  Richard E Gillilan; Stephen D Ayers; Noa Noy
Journal:  J Mol Biol       Date:  2007-08-02       Impact factor: 5.469

8.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

9.  Signaling by retinol and its serum binding protein.

Authors:  Noa Noy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-29       Impact factor: 4.006

Review 10.  How degrading: Cyp26s in hindbrain development.

Authors:  Richard J White; Thomas F Schilling
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.